If this box remains here for more than 30 seconds, click this link to try again.
Products & Services ╗
Best Practice Database
Medical Affairs ╗ Thought Leader Services
Download FREE Excerpt
10 Info Graphics
9 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
While the evolving U.S. healthcare system is altering many aspects of the biopharmaceutical marketplace, the importance of Key Opinion Leaders (KOLs) remains unchanged. The influence of KOLs continues to extend from clinical programs and medical education to prescribing habits and payer access. Consequently, it's vital for biopharmaceutical organizations to effectively manage these important and often complex relationships through systems, processes, and procedures.
Best Practices, LLC conducted this research to help organizations create and maintain a strategic KOL management system. In particular, this study examines current approaches to performance measurement, staffing and success factors for a strategic KOL management system. This study provides an evidence-based understanding of current and evolving approaches to creating and maintaining an integrated, strategically-focused KOL management system.
Thirty-four TL management leaders from 29 biopharma and device organizations participated in the external field survey, and we interviewed 4 participants for in-depth insights
Health Care; Pharmaceutical; Biotech; Medical Device; Manufacturing; Education; Science; Biopharmaceutical; Clinical Research; Laboratories; Medical
Abbott Nutrition; Abbvie; Amgen; Antibiotice; Astellas; Baxter Healthcare; Biogen Idec; Boehringer Ingelheim; Crescendo Bioscience; Cubist Pharmaceuticals; Eisai; Intermune; Janssen; Jazz Pharmaceuticals; Mallinckrodt; Marcyrl; Medtronic; Merck; MSD; Onyx Pharmaceuticals; Pierre Fabre Medicament; ProStrakan; Reliance Institute of Life Sciences; Roche; Sanofi; Sanofi Renal; Servier; Shire; TauRx Therapeutics; Janssen Biotech; Inc.; A.P. Pharma